Evidence map›Paper›PMID 41659918›Full record

ArticleCancer communications (London, England)2026

Multiplexed CRISPR/Cas9 Editing of Tumor Suppressor Genes in the Mouse Endometrium Recapitulates High-Risk Endometrial Carcinoma.

Maria Vidal-Sabanés, Raúl Navaridas, Núria Bonifaci, Ada Gay-Rua, Damià Ortega-Peinado, Joaquim Egea, Mario Encinas, Xavier Matias-Guiu, David Llobet-Navas, Xavier Dolcet

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancer communications (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Maria Vidal-SabanésDevelopmental and Oncogenic Signaling Group, Department of Basic Medical Sciences, University of Lleida, Biomedical Research Institute of Lleida (IRBLleida), Lleida 25198, Lleida, Spain.
Raúl NavaridasHerbert Irving Comprehensive Cancer Center, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY 10032, USA.
Núria BonifaciMolecular Mechanisms and Experimental Therapy in Oncology-Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, 08907 Barcelona, Spain.
Ada Gay-RuaDevelopmental and Oncogenic Signaling Group, Department of Basic Medical Sciences, University of Lleida, Biomedical Research Institute of Lleida (IRBLleida), Lleida 25198, Lleida, Spain.
Damià Ortega-PeinadoDevelopmental and Oncogenic Signaling Group, Department of Basic Medical Sciences, University of Lleida, Biomedical Research Institute of Lleida (IRBLleida), Lleida 25198, Lleida, Spain.
Joaquim EgeaDevelopmental and Oncogenic Signaling Group, Department of Basic Medical Sciences, University of Lleida, Biomedical Research Institute of Lleida (IRBLleida), Lleida 25198, Lleida, Spain.
Mario EncinasDevelopmental and Oncogenic Signaling Group, Department of Basic Medical Sciences, University of Lleida, Biomedical Research Institute of Lleida (IRBLleida), Lleida 25198, Lleida, Spain.
Xavier Matias-GuiuBiomedical Research Networking Center in Oncology (CIBERONC), Carlos III Health Institute (ISCIII), 28029 Madrid, Spain.
David Llobet-NavasMolecular Mechanisms and Experimental Therapy in Oncology-Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, 08907 Barcelona, Spain.
Xavier DolcetDevelopmental and Oncogenic Signaling Group, Department of Basic Medical Sciences, University of Lleida, Biomedical Research Institute of Lleida (IRBLleida), Lleida 25198, Lleida, Spain.ORCID https://orcid.org/0000-0003-1921-0449

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41659918
PMCPMC12876560

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.